杨东孙 began their career in 2016 as Supervisor of Bioassay Analytical Development at 信达生物制药 (Innovent Biologics). 杨东 then progressed to Associate Manager of Global Regulatory Affairs, then Senior Manager of Global Regulatory Affairs, and finally Supervisor of Global Regulatory Affairs. In 2022, they moved to Ractigen Therapeutics as Director of Project Management and Regulatory Affairs.
杨东孙 received a Doctor of Science degree in Biological Engineering from Jilin University between 2012 and 2016.
Links
Org chart
Sign up to view 0 direct reports
Get started